Report : South & Central America Noninvasive Fat Reduction Market Forecast to 2031 - Regional Analysis - by Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others) and End User (Hospitals, Dermatology & Cosmetic Clinics, and Other End Users)
At 12.7% CAGR, South & Central America Noninvasive Fat Reduction Market is Projected to be Worth US$ 224.54 Million by 2031, says Business Market Insights
According to Business Market Insights' research, the South & Central America noninvasive fat reduction market was valued at US$ 86.41 million in 2023 and is anticipated to reach US$ 224.54 million by 2031, recording a CAGR of 12.7% from 2023 to 2031. Robotics to perform noninvasive fat reduction procedures and growing adoption of noninvasive fat reduction procedures are among the critical factors attributed to drive the South & Central America noninvasive fat reduction market growth.
Companies are trying to launch technologically advanced, noninvasive fat-reducing products. Dominion Aesthetic Technologies, Inc.'s EON is one such example. EON includes a programmable articulated robotic arm that uses sensors to map the body's unique topography, providing 100% personalized treatment. Also, the programmable articulated robotic arm understands the body better than other fat contouring machines; it is capable of mapping the entire treatment area, reducing the chances of irregular results and increasing comfort levels. EON is an FDA-cleared product that has been proven safe, effective, and better than laser treatment. Laser treatment targets unwanted fat cells, while EON targets only abdominal fat without causing any harm to the rest of the body, producing effective results. For example, during the apoptosis procedure, EON permanently removes subcutaneous fat cells by delivering consistent and powerful laser energy through the robotic arm, while jet impingement ensures a comfortable and safe patient experience. Treatment by EON only takes about 20 minutes, with the whole treatment being completed within 60 minutes, requiring no downtime. This treatment time is remarkably short compared to other fat-reduction treatment machines that exist in the market. Therefore, such advanced robotic delivery technologies provide effective fat reduction results and patient safety in the long run.
On the contrary, complications associated with noninvasive fat reduction procedures hamper the growth of South & Central America noninvasive fat reduction market.
Based on technology, the South & Central America noninvasive fat reduction market is bifurcated into cryolipolysis, laser lipolysis, ultrasound, and others. The cryolipolysis segment held 56.3% market share in 2023, amassing US$ 48.65 million. It is projected to garner US$ 142.44 million by 2031 to register 14.4% CAGR during 2023-2031.
By end user, the South & Central America noninvasive fat reduction market is divided into hospitals, dermatology clinics & cosmetic clinics, and others. The dermatology clinics & cosmetic clinics segment held 68.6% share of South & Central America noninvasive fat reduction market in 2023, amassing US$ 59.25 million. It is projected to garner US$ 164.29 million by 2031 to expand at 13.6% CAGR from 2023 to 2031.
Based on country, the South & Central America noninvasive fat reduction market is categorized into Brazil, Argentina and the Rest of South & Central America. Our regional analysis states that Brazil captured 62.0% share of South & Central America noninvasive fat reduction market in 2023. It was assessed at US$ 53.59 million in 2023 and is likely to hit US$ 151.52 million by 2031, registering a CAGR of 13.9% during 2023-2031.
Key players operating in the South & Central America noninvasive fat reduction market are Cynosure LLC, Lumenis, Alma Lasers Ltd, Fotona, Venus Concept Inc, and Candela Corporation, among others.
- In April 2021, Alma announced launching of "Alma PrimeX" platform involved in circumference reduction and skin tightening in the abdomen, waist, thighs, and buttock areas.
- In July 2020, Venus Concept Inc. received FDA 510(k) clearance to market and sell Venus Viva MD. Venus Viva MD is a noninvasive device intended to be used by aesthetic-related physicians/dermatologists. It expands the Company's skin rejuvenation offerings beyond the Venus Viva and Venus Versa which were introduced to the medical aesthetics market in 2015 and 2016, respectively.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com